New patent for Intra-cellular drug CAPLYTA

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug. CAPLYTA drug price trends.…
The post New patent for Intra-cellular drug CAPLYTA appeared fi…


Drug Patent Expirations for the Week of January 16, 2022

ALPHAGAN P (brimonidine tartrate) Allergan Patent: 6,627,210 Expiration: Jan 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]
The post Drug…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog